These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 9285589)

  • 21. Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture.
    Maccarrone M; Attinà M; Cartoni A; Bari M; Finazzi-Agrò A
    J Neurochem; 2001 Jan; 76(2):594-601. PubMed ID: 11208922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor-dependent formation of endogenous cannabinoids in cortical neurons.
    Stella N; Piomelli D
    Eur J Pharmacol; 2001 Aug; 425(3):189-96. PubMed ID: 11513837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons.
    Basavarajappa BS; Saito M; Cooper TB; Hungund BL
    Biochim Biophys Acta; 2000 Dec; 1535(1):78-86. PubMed ID: 11113634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.
    Di Marzo V; Melck D; Bisogno T; De Petrocellis L
    Trends Neurosci; 1998 Dec; 21(12):521-8. PubMed ID: 9881850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of pain initiation by endogenous cannabinoids.
    Calignano A; La Rana G; Giuffrida A; Piomelli D
    Nature; 1998 Jul; 394(6690):277-81. PubMed ID: 9685157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.
    Panikashvili D; Simeonidou C; Ben-Shabat S; Hanus L; Breuer A; Mechoulam R; Shohami E
    Nature; 2001 Oct; 413(6855):527-31. PubMed ID: 11586361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol].
    Waku K
    Yakugaku Zasshi; 2006 Feb; 126(2):67-81. PubMed ID: 16462096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous lipids that activate cannabinoid receptors. Formation and inactivation.
    Di Tomaso E; Cadas H; Gaillet S; Beltramo M; Desarnaud F; Venance L; Piomelli D
    Adv Exp Med Biol; 1997; 407():335-40. PubMed ID: 9321973
    [No Abstract]   [Full Text] [Related]  

  • 29. Retrograde signaling by endocannabinoids.
    Kreitzer AC; Regehr WG
    Curr Opin Neurobiol; 2002 Jun; 12(3):324-30. PubMed ID: 12049940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and characterization of endogenous cannabinoids.
    Martin BR; Mechoulam R; Razdan RK
    Life Sci; 1999; 65(6-7):573-95. PubMed ID: 10462059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain.
    Nakane S; Oka S; Arai S; Waku K; Ishima Y; Tokumura A; Sugiura T
    Arch Biochem Biophys; 2002 Jun; 402(1):51-8. PubMed ID: 12051682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
    Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A
    Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Getting stoned without inhaling: anandamide is the brain's natural marijuana.
    Stahl SM
    J Clin Psychiatry; 1998 Nov; 59(11):566-7. PubMed ID: 9862600
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of intestinal motility by anandamide, an endogenous cannabinoid.
    Calignano A; La Rana G; Makriyannis A; Lin SY; Beltramo M; Piomelli D
    Eur J Pharmacol; 1997 Dec; 340(2-3):R7-8. PubMed ID: 9537804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gastrointestinal pharmacology of cannabinoids.
    Izzo AA; Mascolo N; Capasso F
    Curr Opin Pharmacol; 2001 Dec; 1(6):597-603. PubMed ID: 11757815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue.
    Kempe K; Hsu FF; Bohrer A; Turk J
    J Biol Chem; 1996 Jul; 271(29):17287-95. PubMed ID: 8663381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum.
    Giuffrida A; Parsons LH; Kerr TM; Rodríguez de Fonseca F; Navarro M; Piomelli D
    Nat Neurosci; 1999 Apr; 2(4):358-63. PubMed ID: 10204543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P2X7 receptors control 2-arachidonoylglycerol production by microglial cells.
    Witting A; Walter L; Wacker J; Möller T; Stella N
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3214-9. PubMed ID: 14976257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The endogenous cannabinoid system and the treatment of marijuana dependence.
    Piomelli D
    Neuropharmacology; 2004; 47 Suppl 1():359-67. PubMed ID: 15464150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-arachidonoylglycerol: an endogenous cannabinoid receptor agonist.
    Sugiura T; Waku K
    World Rev Nutr Diet; 2001; 88():200-6. PubMed ID: 11935957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.